GCM
INSM icon

Graham Capital Management’s Insmed INSM Stock Holding History

Graham Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-18,071
Closed -$490K – 1185
2024
Q1 		$490K Buy
18,071
+6,763
+60% +$189K 0.01% 634
2023
Q4 		$350K Sell
11,308
-32,297
-74% -$837K 0.01% 686
2023
Q3 		$1.1M Buy
43,605
+33,969
+353% +$777K 0.03% 336
2023
Q2 		$203K Buy
+9,636
New +$183K 0.01% 816
2022
Q4 		– Sell
-93,440
Closed -$2.01M – 1168
2022
Q3 		$2.01M Buy
+93,440
New +$2.24M 0.08% 225

Other funds holding INSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Graham Capital Management's INSM Position: Q2 2024 in Review

Graham Capital Management sold out of Insmed (INSM) in Q2 2024, closing a stake of 18,071 shares — an estimated $490K sold.

Graham Capital Management first reported a position in INSM in Q3 2022 and held it in 5 quarters. The position peaked at $2.01M in Q3 2022. 378 funds tracked by Wall St. Rank hold INSM as of Q2 2024.

  • Graham Capital Management reported no remaining Insmed position as of Q2 2024 after selling out during the quarter.
  • Graham Capital Management sold 18,071 Insmed shares in Q2 2024, an estimated $490K.
  • Graham Capital Management first reported a position in Insmed in Q3 2022 and held it in 5 quarters.
  • Graham Capital Management's Insmed position peaked at $2.01M in Q3 2022.
  • 378 funds tracked by Wall St. Rank held Insmed as of Q2 2024.

Based on Graham Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.